Conclusions
Biomarkers of acute myocardial injury play an important role in
predicting worsening prognosis for COVID-19 patients with and without
myocardial injury. Elevated TnT, CK-MB and NT-pro-BNP levels correlate
with more severe symptoms of COVID-19. There are in fact not only
predictive of disease severity, but are also helpful for therapeutic
management, based on drugs preventing the activation of coagulation
processes. It’s important, above all, to identify a laboratory score,
made by hematological, inflammatory, biochemical (above all TnT,
NT-pro-BNP and CK-MB) and immunological parameters, may help to stratify
COVID-19 positive patients into risk categories for deciding therapeutic
management, thus avoiding cardiac compromise which, as we have
previously analyzed, is an indication of a poor prognosis.